STAT+: Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is strawberry creme — and get started. To help you along, we have assembled another menu of tidbits for you to peruse. Meanwhile, do keep us in mind if you hear anything interesting. We continue to accept — at absolutely no charge to you — postcards and telegrams. And of course, we hope you have a smashing day. …

AbbVie announced that chief executive officer Richard Gonzalez, who has managed its ascent since being spun off from Abbott Laboratories in 2013, will step down in July, STAT notes. Gonzalez previously said he would…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks